
|Articles|December 3, 2021
Daily Medication Pearl: Loteprednol Etabonate (Lotemax)
Author(s)Saro Arakelians, PharmD
Lotemax treats post-operative inflammation and pain following ocular surgery.
Advertisement
Medication Pearl of the Day: Loteprednol Etabonate (Lotemax)
Indication: Lotemax is a corticosteroid indicated for the treatment of post-operative inflammation and pain following ocular surgery.
Insight:
- Dosing:Apply 1 to 2 drops of Lotemax into the conjunctival sac of the affected eye 4 times daily beginning the day after surgery and continuing throughout the first 2 weeks of the post-operative period.
- Dosage forms: Lotemax contains 5 mg/g of loteprednol etabonate, as a sterile preserved ophthalmic gel.
- Adverse events: The most common adverse drug reactions were anterior chamber inflammation (5%), eye pain (2%), and foreign body sensation.
- Mechanism of action: Corticosteroids inhibit the inflammatory response to a variety of inciting agents and probably delay or slow healing. They inhibit the edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen, and scar formation associated with inflammation.
- Manufacturer: Bausch & Lamb
Sources:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Men Face Higher Odds of Later-Stage Diagnosis Across 20 Cancer Types
2
FDA Accepts NDA for AD109 to Treat of Adults With Obstructive Sleep Apnea
3
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
4
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
5






































































































